Dabrafenib
Cat.No:ID2480 Solarbio
CAS:1195765-45-7
Molecular Formula:C23H20F3N5O2S2
Molecular Weight:519.56
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > MAPK > DabrafenibCAS:1195765-45-7
Molecular Formula:C23H20F3N5O2S2
Molecular Weight:519.56
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 1195765-45-7 |
| Name | Dabrafenib |
| Molecular Formula | C23H20F3N5O2S2 |
| Molecular Weight | 519.56 |
| Solubility | Soluble in DMSO ≥5mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 689-166-9 |
| MDL | MFCD17215684 |
| SMILES | CC(C)(C)C1=NC(C2=C(F)C(NS(C3=C(F)C=CC=C3F)(=O)=O)=CC=C2)=C(C4=CC=NC(N)=N4)S1 |
| Target Point | Raf |
| Passage | MAPK |
| Background | It is an ATP-competitive Raf inhibitor. |
| Biological Activity | Dabrafenib是ATP竞争型的 Raf 抑制剂,抑制 C-Raf 和 B-RafV600E 的 IC50 分别为 5 nM 和 0.6 nM。[1-5] |
| IC50 | B-RafV600E:0.6nM;C-RAF:5nM [1-5] |
| Data Literature Source | [1]. Greger JG,et al. Combinations of BRAF,MEK,and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib,mediated by NRAS or MEK mutations. Mol Cancer Ther,2012,11(4),909-920. [2]. Lee S,et al. Anti-inflammatory effects of dabrafenib on polyphosphate-mediated vascular disruption. Chem Biol Interact. 2016 Jul 22. [3]. Jung B,et al. Anti-septic effects of dabrafenib on HMGB1-mediated inflammatory responses. BMB Rep. 2016 Apr;49(4):214-9. [4]. Alexander M Menzies,et al. Dabrafenib and its potential for the treatment of metastatic melanoma. Drug Des Devel Ther. 2012; 6: 391–405. [5]. Posobiec LM,et al. Early Vaginal Opening in Juvenile Female Rats Given BRAF-Inhibitor Dabrafenib Is Not Associated with Early Physiologic Sexual Maturation. Birth Defects Res B Dev Reprod Toxicol. 2015 Dec;104(6):244-52. |
| Unit | Bottle |
| Specification | 5mg 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download